Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Cognitive Impairment with Mild Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Menu
Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Cognitive Impairment with Mild Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Investors
Investor Relations Contact
Investor Relations Contact
Investor Relations
Don Kalkofen, CFO
info@alphacognition.com
Investors
Quick Links
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
View Video
Read More
Latest News
View All
View All
TSX-V: ACI
15 min delay
Last
$9.47
Change
$0.16
Open
9.3
Vol
900739
High
9.57
Low
9.14
Stock Information
